메뉴 건너뛰기




Volumn 15, Issue 19, 2009, Pages 6167-6176

Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN E7; PROTEIN E7[49-57]; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

EID: 70349662169     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0645     Document Type: Article
Times cited : (28)

References (34)
  • 1
    • 0036559896 scopus 로고    scopus 로고
    • Papillomaviruses and cancer: From basic studies to clinical application
    • zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-350
    • (2002) Nat Rev Cancer , vol.2 , pp. 342-350
    • Zur Hausen, H.1
  • 2
    • 42149123438 scopus 로고    scopus 로고
    • Therapeutic human papillomavirus vaccines: Current clinical trials and future directions
    • DOI 10.1517/14712598.8.4.421
    • Hung C, Ma B, Monie A, Tsen S, Wu T. Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin BiolTher 2008;8:421-439 (Pubitemid 351570408)
    • (2008) Expert Opinion on Biological Therapy , vol.8 , Issue.4 , pp. 421-439
    • Hung, C.-F.1    Ma, B.2    Monie, A.3    Tsen, S.-W.4    Wu, T.-C.5
  • 3
    • 0035888074 scopus 로고    scopus 로고
    • Estimating the world cancer burden: Globocan 2000
    • Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156
    • (2001) Int J Cancer , vol.94 , pp. 153-156
    • Parkin, D.M.1    Bray, F.2    Ferlay, J.3    Pisani, P.4
  • 4
    • 0029041842 scopus 로고
    • Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
    • International biological study on cervical cancer (IBSCC) Study Group
    • Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87: 796-802.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 796-802
    • Bosch, F.X.1    Manos, M.M.2    Munoz, N.3
  • 6
    • 14844355235 scopus 로고    scopus 로고
    • Human papillomavirus vaccine: History, immunology, current status, and future prospects
    • DOI 10.1097/01.grf.0000151585.16357.e6
    • Padilla-Paz LA. Human papillomavirus vaccine: history, immunology, current status, and future prospects. Clin Obstet Gynecol 2005;48:226-240 (Pubitemid 40354392)
    • (2005) Clinical Obstetrics and Gynecology , vol.48 , Issue.1 , pp. 226-240
    • Padilla-Paz, L.A.1
  • 9
    • 20844455173 scopus 로고    scopus 로고
    • Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration
    • DOI 10.1002/eji.200526124
    • von Beust BR, Johansen P, Smith KA, Bot A, Storni T, Kundig TM. Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur J Immunol 2005; 35:1869-1876 (Pubitemid 40862335)
    • (2005) European Journal of Immunology , vol.35 , Issue.6 , pp. 1869-1876
    • Von Beust, B.R.1    Johansen, P.2    Smith, K.A.3    Bot, A.4    Storni, T.5    Kundig, T.M.6
  • 10
    • 63449140410 scopus 로고    scopus 로고
    • Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides
    • Smith KA, Tam VL, Wong RM, et al. Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 2009;27:2603-2615
    • (2009) Vaccine , vol.27 , pp. 2603-2615
    • Smith, K.A.1    Tam, V.L.2    Wong, R.M.3
  • 11
    • 0027320440 scopus 로고
    • Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
    • Feltkamp MC, Smits HL, Vierboom MP, et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993;23:2242-2249
    • (1993) Eur J Immunol , vol.23 , pp. 2242-2249
    • Feltkamp, M.C.1    Smits, H.L.2    Vierboom, M.P.3
  • 12
    • 0029030393 scopus 로고
    • Fibroblasts as efficient antigen-presenting cells in lymphoid organs
    • Kundig TM, Bachmann MF, DiPaolo C, et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995;268:1343-1347
    • (1995) Science , vol.268 , pp. 1343-1347
    • Kundig, T.M.1    Bachmann, M.F.2    DiPaolo, C.3
  • 13
    • 44949242538 scopus 로고    scopus 로고
    • Phase 1 Trial of intranodal injection of a Melan-A/ MART-1 DNA plasmid vaccine in patients with stage IV melanoma
    • Weber J, Boswell W, Smith J, et al. Phase 1 Trial of intranodal injection of a Melan-A/ MART-1 DNA plasmid vaccine in patients with stage IV melanoma. J Immunother 2008; 31:215-223
    • (2008) J Immunother , vol.31 , pp. 215-223
    • Weber, J.1    Boswell, W.2    Smith, J.3
  • 14
    • 0036801463 scopus 로고    scopus 로고
    • Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
    • DOI 10.1172/JCI200215536
    • Wang L, Smith D, Bot S, Dellamary L, Bloom A, Bot A. Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J Clin Invest 2002;110: 1175-1184 (Pubitemid 35215898)
    • (2002) Journal of Clinical Investigation , vol.110 , Issue.8 , pp. 1175-1184
    • Wang, L.1    Smith, D.2    Bot, S.3    Dellamary, L.4    Bloom, A.5    Bot, A.6
  • 15
    • 34249677845 scopus 로고    scopus 로고
    • Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
    • DOI 10.1038/nm1589, PII NM1589
    • Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007;13:552-559 (Pubitemid 46830615)
    • (2007) Nature Medicine , vol.13 , Issue.5 , pp. 552-559
    • Kanzler, H.1    Barrat, F.J.2    Hessel, E.M.3    Coffman, R.L.4
  • 16
    • 34248194231 scopus 로고    scopus 로고
    • Tregs and rethinking cancer immunotherapy
    • CurielTJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007;117:1167-1174
    • (2007) J Clin Invest , vol.117 , pp. 1167-1174
    • Curiel, T.J.1
  • 17
    • 0035328683 scopus 로고    scopus 로고
    • Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
    • Machiels JPH, Reilly RT, Emens LA, et al. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage- colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001;61:3689-3697
    • (2001) Cancer Res , vol.61 , pp. 3689-3697
    • Machiels, J.P.H.1    Reilly, R.T.2    Emens, L.A.3
  • 19
    • 33644531900 scopus 로고    scopus 로고
    • Chemoimmunotherapy of tumors: Cyclophosphamide synergizes with exosome based vaccines
    • Taieb J, Chaput N, Schartz N, et al. Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines. J Immunol 2006;176:2722-2729
    • (2006) J Immunol , vol.176 , pp. 2722-2729
    • Taieb, J.1    Chaput, N.2    Schartz, N.3
  • 20
    • 26644448965 scopus 로고    scopus 로고
    • Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model
    • DOI 10.1016/j.vaccine.2005.04.049, PII S0264410X05006274
    • Vambutas A, DeVoti J, Nouri M, et al. Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model. Vaccine 2005;23: 5271-5280 (Pubitemid 41443433)
    • (2005) Vaccine , vol.23 , Issue.45 , pp. 5271-5280
    • Vambutas, A.1    Devoti, J.2    Nouri, M.3    Drijfhout, J.W.4    Lipford, G.B.5    Bonagura, V.R.6    Van Der Burg, S.H.7    Melief, C.J.M.8
  • 21
    • 0032889347 scopus 로고    scopus 로고
    • Phase I safety and antigenicity of TA-GW: A recombinant HPV6 L2E7 vaccine for the treatment of genital warts
    • Thompson HS, Davies ML, Holding FP, et al. Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts. Vaccine 1999;17: 40-49
    • (1999) Vaccine , vol.17 , pp. 40-49
    • Thompson, H.S.1    Davies, M.L.2    Holding, F.P.3
  • 22
    • 33744505292 scopus 로고    scopus 로고
    • Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion
    • DOI 10.1016/j.vaccine.2006.03.079, PII S0264410X06003963
    • Daftarian P, Mansour M, Benoit AC, et al. Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T help fusion peptide in a water-in-oilemul sion. Vaccine 2006;24:5235-5244 (Pubitemid 43818188)
    • (2006) Vaccine , vol.24 , Issue.24 , pp. 5235-5244
    • Daftarian, P.1    Mansour, M.2    Benoit, A.C.3    Pohajdak, B.4    Hoskin, D.W.5    Brown, R.G.6    Kast, W.M.7
  • 23
    • 33846921847 scopus 로고    scopus 로고
    • Listeria based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse modelof cancer
    • Souders NC, Sewell DA, Pan ZK, et al. Listeria based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse modelof cancer. Cancer Immun 2007;7:2.
    • (2007) Cancer Immun , vol.7 , pp. 2
    • Souders, N.C.1    Sewell, D.A.2    Pan, Z.K.3
  • 25
    • 0034802089 scopus 로고    scopus 로고
    • Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site
    • Lamikanra A, Pan ZK, Isaacs SN, Wu TC, Paterson YJ. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site. Virol 2001;75:9654-9664
    • (2001) Virol , vol.75 , pp. 9654-9664
    • Lamikanra, A.1    Pan, Z.K.2    Isaacs, S.N.3    Wu, T.C.4    Paterson, Y.J.5
  • 26
    • 0030068375 scopus 로고    scopus 로고
    • Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
    • Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996;56:21-26
    • (1996) Cancer Res , vol.56 , pp. 21-26
    • Lin, K.Y.1    Guarnieri, F.G.2    Staveley-O'Carroll, K.F.3
  • 27
    • 0346995215 scopus 로고    scopus 로고
    • Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection
    • DOI 10.1128/JVI.78.1.116-123.2004
    • Brandsma JL, Shlyankevich M, Zhang L, et al. Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection. J Virol 2004;78:116-123 (Pubitemid 37549724)
    • (2004) Journal of Virology , vol.78 , Issue.1 , pp. 116-123
    • Brandsma, J.L.1    Shlyankevich, M.2    Zhang, L.3    Slade, M.D.4    Goodwin, E.C.5    Peh, W.6    Deisseroth, A.B.7
  • 28
    • 34247626477 scopus 로고    scopus 로고
    • Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice
    • DOI 10.1007/s00262-006-0247-2
    • Gomez-Gutierrez JG, Elpek KG, Montes de Oca- Luna R, Shirwan H, Sam Zhou H, McMasters KM. Vaccination with an adenoviralvector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer ImmunolImmuno ther 2007;56:997-1007. (Pubitemid 46675294)
    • (2007) Cancer Immunology, Immunotherapy , vol.56 , Issue.7 , pp. 997-1007
    • Gomez-Gutierrez, J.G.1    Elpek, K.G.2    Montes De Oca-Luna, R.3    Shirwan, H.4    Sam Zhou, H.5    McMasters, K.M.6
  • 29
    • 0034306991 scopus 로고    scopus 로고
    • Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell based vaccination against human papillomavirus 16-induced tumor cells in a murine model
    • Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, CurielD T. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Cancer Res 2000;60:5456-5463
    • (2000) Cancer Res , vol.60 , pp. 5456-5463
    • Tillman, B.W.1    Hayes, T.L.2    DeGruijl, T.D.3    Douglas, J.T.4    Curield, T.5
  • 30
    • 0034061398 scopus 로고    scopus 로고
    • Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity
    • DOI 10.1038/sj/gt/3301160
    • Wang TL, Ling M, Shih IM, et al. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gen Ther 2000;7:726-733. (Pubitemid 30255753)
    • (2000) Gene Therapy , vol.7 , Issue.9 , pp. 726-733
    • Wang, T.-L.1    Ling, M.2    Shih, I.-M.3    Pham, T.4    Pai, S.I.5    Lu, Z.6    Kurman, R.J.7    Pardoll, D.M.8    Wu, T.-C.9
  • 31
    • 23744472184 scopus 로고    scopus 로고
    • Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope
    • DOI 10.1038/sj.gt.3302519
    • Huang CH, Peng S, He L, et al. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. Gene Ther 2005;12:1180-1186 (Pubitemid 41136312)
    • (2005) Gene Therapy , vol.12 , Issue.15 , pp. 1180-1186
    • Huang, C.-H.1    Peng, S.2    He, L.3    Tsai, Y.-C.4    Boyd, D.A.K.5    Hansen, T.H.6    Wu, T.-C.7    Hung, C.-F.8
  • 33
    • 24944478531 scopus 로고    scopus 로고
    • Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
    • DOI 10.1158/0008-5472.CAN-05-1797
    • Emens LA, Jaffee EM. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. Cancer Res 2005;65:8059-8064 (Pubitemid 41330564)
    • (2005) Cancer Research , vol.65 , Issue.18 , pp. 8059-8064
    • Emens, L.A.1    Jaffee, E.M.2
  • 34
    • 66249095192 scopus 로고    scopus 로고
    • Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model
    • Wada S, Yoshimura K, Hipkiss EL, et al. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res 2009;69:4309-4318
    • (2009) Cancer Res , vol.69 , pp. 4309-4318
    • Wada, S.1    Yoshimura, K.2    Hipkiss, E.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.